Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real‐world data from a large multi‐national UCARE study.

Autor:	Soegiharto, R.1 (AUTHOR) r.soegiharto@umcutrecht.nl, Alizadeh Aghdam, M.1 (AUTHOR), Sørensen, J. A.2 (AUTHOR), Lindonk, E.3 (AUTHOR), Bulut Demir, F.4 (AUTHOR), Mohammad Porras, N.5 (AUTHOR), Matsuo, Y.6 (AUTHOR), Kiefer, L.7,8 (AUTHOR), Knulst, A. C.1 (AUTHOR), Maurer, M.7,8 (AUTHOR), Ritchie, C.9 (AUTHOR), Rudenko, M.10 (AUTHOR), Kocatürk, E.7,11 (AUTHOR), Criado, R. F. J.12 (AUTHOR), Gregoriou, S.13 (AUTHOR), Bobylev, T.14 (AUTHOR), Kleinheinz, A.14 (AUTHOR), Takahagi, S.6 (AUTHOR), Hide, M.6,15 (AUTHOR), Giménez‐Arnau, A. M.5 (AUTHOR)
Zdroj:	Allergy. Oct2024, p1. 11p. 3 Illustrations.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Plný text